Metformin for the Prevention of Oral Cancer in Patients With Oral Premalignant Lesions

NCT05536037 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

4

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Erythroplakia
Leukoplakia
Oral Cavity Carcinoma
Proliferative Verrucous Leukoplakia

Interventions

DRUG: Metformin
PROCEDURE: Biopsy

Sponsor

Thomas Jefferson University